QILIAN INTERNATIONAL HOLDING (QLI) Stock Price, Forecast & Analysis

NASDAQ:QLI • KYG7307E1237

5.41 USD
-0.35 (-6.08%)
Last: Aug 9, 2024, 08:09 PM

QLI Key Statistics, Chart & Performance

Key Statistics
Market Cap38.68M
Revenue(TTM)46.47M
Net Income(TTM)-7.78M
Shares7.15M
Float1.61M
52 Week High6.69
52 Week Low1.78
Yearly Dividend0.08
Dividend YieldN/A
EPS(TTM)-1.09
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2021-01-12
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
QLI short term performance overview.The bars show the price performance of QLI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40 60 80

QLI long term performance overview.The bars show the price performance of QLI in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 -40 -60

The current stock price of QLI is 5.41 USD. In the past month the price increased by 26.7%. In the past year, price increased by 27.37%.

QILIAN INTERNATIONAL HOLDING / QLI Daily stock chart

QLI Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to QLI. When comparing the yearly performance of all stocks, QLI is one of the better performing stocks in the market, outperforming 93.62% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
QLI Full Technical Analysis Report

QLI Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to QLI. While QLI seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
QLI Full Fundamental Analysis Report

QLI Financial Highlights

Over the last trailing twelve months QLI reported a non-GAAP Earnings per Share(EPS) of -1.09. The EPS decreased by -3727.33% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -15.18%
ROE -18.18%
Debt/Equity 0.01
Chartmill High Growth Momentum
EPS Q2Q%-3958.33%
Sales Q2Q%-47.18%
EPS 1Y (TTM)-3727.33%
Revenue 1Y (TTM)-28.35%
QLI financials

QLI Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
QLI Analyst EstimatesQLI Analyst Ratings

QLI Ownership

Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
QLI Ownership

QLI Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
LLY ELI LILLY & CO30.38964.817B
JNJ JOHNSON & JOHNSON21.09590.254B
MRK MERCK & CO. INC.22.51301.963B
PFE PFIZER INC8.89155.618B
BMY BRISTOL-MYERS SQUIBB CO9.84121.595B
ZTS ZOETIS INC18.5756.906B
RPRX ROYALTY PHARMA PLC- CL A8.7126.172B
VTRS VIATRIS INC6.2618.486B
ELAN ELANCO ANIMAL HEALTH INC23.9512.312B
AXSM AXSOME THERAPEUTICS INC224.769.313B

About QLI

Company Profile

QLI logo image Qilian International Holding Group Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Jiuquan, Gansu and currently employs 298 full-time employees. The company went IPO on 2021-01-12. Qilian International Holding Group Ltd is a China-based company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. Its main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.

Company Info

QILIAN INTERNATIONAL HOLDING

No. 152 Hongliang East 1St Street, No. 1703, Tianfu New District

Jiuquan GANSU 735000 CN

CEO: Zhanchang Xin

Employees: 298

QLI Company Website

Phone: 8609372689523

QILIAN INTERNATIONAL HOLDING / QLI FAQ

What does QILIAN INTERNATIONAL HOLDING do?

Qilian International Holding Group Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Jiuquan, Gansu and currently employs 298 full-time employees. The company went IPO on 2021-01-12. Qilian International Holding Group Ltd is a China-based company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. Its main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.


Can you provide the latest stock price for QILIAN INTERNATIONAL HOLDING?

The current stock price of QLI is 5.41 USD. The price decreased by -6.08% in the last trading session.


What is the dividend status of QILIAN INTERNATIONAL HOLDING?

QLI does not pay a dividend.


What is the ChartMill technical and fundamental rating of QLI stock?

QLI has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


How is the valuation of QILIAN INTERNATIONAL HOLDING (QLI) based on its PE ratio?

QILIAN INTERNATIONAL HOLDING (QLI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.09).